|
|
 |
|
|
|
CryptoTrol™
For use as an unassayed quality control with assays detecting capsular polysaccharide antigens of Cryptococcus neoformans.
- Human serum based
- 60 day open-vial stability at 2–8º C
|
ANALYTE
Cryptococcus neoformans Ag
Refer to the package insert for performance and stability claims
|
|
|
CryptoTrol™ LX
For use as an unassayed quality control in enzyme immunoassay and latex agglutination based test systems for qualitative and semi-quantitative detection of capsular polysaccharide antigens of Cryptococcus neoformans.
- Human serum based
- 60 day open-vial stability at 2–8º C
|
ANALYTE
Cryptococcus neoformans Ag
Refer to the package insert for performance and stability claims
|
|
|
VIROCLEAR® EBV
For use as an unassayed, non-reactive quality control with assays detecting IgG and IgM antibodies to the viral capsid antigen of Epstein-Barr Virus, IgG antibodies to early antigen and IgG antibodies to the viral polypeptide nuclear antigen of Epstein-Barr Virus.
- Human serum based
- 60 day open-vial stability at 2–8º C
|
ANALYTES
Epstein-Barr Virus (VCA) IgG
Epstein-Barr Virus (VCA) IgM
EBV EA IgG
EBNA IgG
Refer to the package insert for performance and stability claims
|
|
|
VIROTROL® EBV
For use as an unassayed quality control with assays detecting IgG and IgM antibodies to the viral capsid antigen of Epstein-Barr virus and IgG antibodies to Epstein-Barr virus nuclear antigen.
- Human serum based
- 60 day open-vial stability at 2–8º C
|
ANALYTES
Epstein-Barr Virus (VCA) IgG
Epstein-Barr Virus (VCA) IgM
EBNA IgG
Refer to the package insert for performance and stability claims
|
|
|
VIROTROL® WNV
An unassayed quality control for use with assays detecting Immunoglobulin G and Immunoglobulin M antibodies to West Nile Virus.
- Human serum based
- 60 day open-vial stability at 2–8º C
|
ANALYTES
West Nile Virus IgG
West Nile Virus IgM
Refer to the package insert for performance and stability claims
|
|
|
PneumoTrol™
For use as an unassayed quality control with assays detecting IgG and IgM antibodies to Mycoplasma pneumoniae and IgG antibodies to Chlamydia species.
- Human serum based
- 60 day open-vial stability at 2–8º C
|
ANALYTES
Mycoplasma pneumoniae IgG
Mycoplasma pneumoniae IgM
Chlamydia trachomatis IgG
Refer to the package insert for performance and stability claims
|
|
|
PyloriTrol™
For use as an unassayed quality controlwith assays detecting IgG antibodies toHelicobacter pylori.
- Human serum based
- 60 day open-vial stability at 2–8º C
|
ANALYTE
Helicobacter pylori IgG
Refer to the package insert for performance and stability claims
|
|
|
VIROTROL® Lyme
For use as an unassayed quality control with assays detecting Immunoglobulin G antibodies to Borrelia burgdorferi.
- Human serum based
- 60 day open-vial stability at 2–8º C
- Convenient liquid formulation eliminates potential reconstitution variability
|
ANALYTE
Borrelia burgdorferi IgG
Refer to the package insert for performance and stability claims
|
|
|
VIROTROL® Chagas
An unassayed, reactive quality control for use with assays for the qualitative detection of antibodies to Trypanosoma cruzi (T. cruzi) in human serum or plasma. T. cruzi is characteristically associated with Chagas disease.
- Human serum based
- Liquid stable, ready to use
- 2 year shelf life at 2–8°C
- 60 day open-vial stability at 2–8º C
|
ANALYTE
Trypanosoma cruzi (T. cruzi)
Refer to the package insert for performance and stability claims
|